Skip to main content
OpenTrials

Clinical trial condition

Stage III Hepatocellular Carcinoma AJCC v8

Explore clinical trials studying Stage III Hepatocellular Carcinoma AJCC v8. Study availability and eligibility vary by location and protocol.

23 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Stage III Hepatocellular Carcinoma AJCC v8 trial results

Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

NCT07166406

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +11 more
Locations
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park Cameron Park, California, United States
  • Palo Alto Medical Foundation-Fremont Fremont, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 139 locations
View Trial Details
Recruiting

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

NCT05168163

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Cleveland Clinic Weston Florida Weston, Florida, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 16 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

NCT06811116

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer

NCT07174570

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +12 more
Locations
  • Grady Health System Atlanta, Georgia, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details

Related conditions